We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Analytical Cannabis Logo
Home > Resources > Videos > Content Piece

Deconstructing Powerful Drugs To Make Better Medicine

Published: Mar 04, 2023   

Speaking back in May 2022, Dr. Boris Heifets, Assistant Professor, Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University School of Medicine, discussed the future of psychedelics.

Abstract: Psychedelic-class drugs like psilocybin, ketamine and MDMA are powerful probes of conscious states with tremendous promise for an array of psychiatric conditions. Each compound has a unique set of effects, some desirable and others less-so, often dependent on the setting in which they are given. As recent drug development efforts have shown, designing targeted, safer drugs requires more than an understanding of brain receptors. Rather, our understanding must bridge pharmacology, large scale neural dynamics, and behavior, and do so in a way that accounts for the tremendous differences between humans and experimental animal models. What makes MDMA special when taken in a group? Is ketamine an opioid? Does one need to conscious and fully aware to experience the benefit of these therapies? Our research group works with both human patients and mouse models to addresses some of these questions.

  More Information

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter